The European Commission Friday cleared pharmaceuticals company Merck & Co. (MRK) to buy Schering-Plough Corp. (SGP).

Merck is paying $41.1 billion in cash and stock for Schering.

To avoid antitrust problems, Merck has sold its 50% stake in animal-health company Merial Limited to Sanofi-Aventis SA (SNY), its partner in the joint venture.

-By Adam Cohen, Dow Jones Newswires; +322 741 1486; adam.cohen@dowjones.com
Schering Plough (NYSE:SGP)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Schering Plough Charts.
Schering Plough (NYSE:SGP)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Schering Plough Charts.